Mustafa N. Mithaiwala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mustafa N. Mithaiwala has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Ashley Acheson
Department of Psychiatry and Behavioral Science, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
3 shared publications - Jason C. O'COnnor
Department of Pharmacology, University of Texas Health San Antonio, San Antonio, TX 78229, USA
3 shared publications Peter Kochunov
3 shared publications- Allison M Garrison
Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
2 shared publications Ashley Acheson
2 shared publicationsL. Elliot Hong
Department of Psychiatry and Behavioral Science University of Texas Health Science Center Houston Texas USA
2 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Elsevier in Addiction Neuroscience
- Vol. 21
Family history of alcohol and other substance use disorders integrated with associated phenotypic characteristics reveal brain structural differences in non-abusing young adults
- 5 October 2026
- Published by Elsevier in Addiction Neuroscience
- Vol. 21
Open AccessFamily history of alcohol and other substance use disorders integrated with associated phenotypic characteristics reveal brain structural differences in non-abusing young adults
- Open Access
- 28 May 2026
- Published by Elsevier in SSRN Electronic Journal
Integrated Family History Measures Identify Brain Structural Differences Associated with Risk for Alcohol and Other Substance Use Disorders
Early adulthood is a critical developmental period for the emergence of alcohol and substance use disorders (A/SUD). Young adults with family histories of A/SUD (FH+) have a higher risk for developing A/SUD themselves compared to individuals without such family histories (FH−). FH+ individuals often exhibit behavioral and cognitive alterations similar to those observed in A/SUD populations; however, A/SUD-related structural brain alterations have not been consistently observed in FH+ neuroimaging studies, which may reflect underlying heterogeneity in FH+ individuals. We compared n=79 FH+ and 128 FH− young adults (ages 18-25) on five regions of interest brain volumes identified from prior A/SUD neuroimaging mega-analyses. Additionally, we compared study participants who scored low and high on a novel family history integrated phenotype (FHIP) score that combined family history with key phenotypic variables related to FH+ status. FH+ participants displayed trend-level reductions in corpus callosum volumes compared to FH− participants. However, participants with high FHIP scores had significantly decreased whole corpus callosum and increased amygdala volumes compared to participants with low FHIP scores. Post hoc testing of corpus callosum subregions found that participants with high FHIP scores had significantly reduced mid-anterior corpus callosum volume. There were no differences in hippocampus, thalamus, or putamen volumes between FH or FHIP score-based groupings. FHIP scores were more sensitive than family history status alone in identifying structural brain differences in non-abusing healthy young adults. Corpus callosum and amygdala structural alterations present before the onset of A/SUD could represent potential neural substrates that contribute to higher A/SUD vulnerability.
- 28 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessIntegrated Family History Measures Identify Brain Structural Differences Associated with Risk for Alcohol and Other Substance Use Disorders
Early adulthood is a critical developmental period for the emergence of alcohol and substance use disorders (A/SUD). Young adults with family histories of A/SUD (FH+) have a higher risk for developing A/SUD themselves compared to individuals without such family histories (FH−). FH+ individuals often exhibit behavioral and cognitive alterations similar to those observed in A/SUD populations; however, A/SUD-related structural brain alterations have not been consistently observed in FH+ neuroimaging studies, which may reflect underlying heterogeneity in FH+ individuals. We compared n=79 FH+ and 128 FH− young adults (ages 18-25) on five regions of interest brain volumes identified from prior A/SUD neuroimaging mega-analyses. Additionally, we compared study participants who scored low and high on a novel family history integrated phenotype (FHIP) score that combined family history with key phenotypic variables related to FH+ status. FH+ participants displayed trend-level reductions in corpus callosum volumes compared to FH− participants. However, participants with high FHIP scores had significantly decreased whole corpus callosum and increased amygdala volumes compared to participants with low FHIP scores. Post hoc testing of corpus callosum subregions found that participants with high FHIP scores had significantly reduced mid-anterior corpus callosum volume. There were no differences in hippocampus, thalamus, or putamen volumes between FH or FHIP score-based groupings. FHIP scores were more sensitive than family history status alone in identifying structural brain differences in non-abusing healthy young adults. Corpus callosum and amygdala structural alterations present before the onset of A/SUD could represent potential neural substrates that contribute to higher A/SUD vulnerability.
- Open Access
- 19 October 2025
- Published by Wiley in Addiction Biology
- Vol. 30 (10) , e70089
Family History of Substance Use and Stressful Life Events Impact Adolescent Maturation of Cerebral White Matter
Family history (FH) of substance use disorders (SUDs) and stressful life events (SLEs) are known risk factors for SUDs in adolescents and young adults. Cross‐sectional studies suggest that FH and SLEs affect adolescent white matter (WM) development and form abnormal WM patterns. Here, we examined the effects of FH, SLEs and their interaction on WM integrity in youths in the Adolescent Cognitive Brain Development (ABCD) study at baseline and 2‐ and 4‐year follow‐ups. ABCD youths ( N = 8939, age ± SD = 9.9 ± 0.6 years, 4302 female) completed baseline diffusion tensor imaging, of which 5661 repeated the scan at 2‐year follow‐up (age ± SD = 12.0 ± 0.7 years, 2634 female) and 2177 at 4‐year follow‐up (age ± SD = 14.1 ± 0.7 years, 1007 female). FH was measured as the weighted sum of biological parents and grandparents with alcohol and/or drug problems. SLEs were measured with parental report of life events. WM integrity was measured with fractional anisotropy (FA) of 23 WM tracts. Linear mixed effect models were used to examine the effects of FH, SLEs and their interaction on FA at baseline and longitudinally, modelling family and study site as random intercepts and correcting for multiple comparisons with false discovery rate (FDR) q = 0.05. At baseline, there were no significant effects of FH, SLEs and their interaction on FA after multiple comparison correction when controlling for race, family income and parental education. From baseline to 4‐year follow‐up, FH significantly negatively interacted with newly occurred SLEs on FA in 19 out of 23 tracts, so that FA at 4‐year was lower in youths with both FH and newly occurred SLEs when controlling for baseline FA ( β interaction = −0.049 − −0.018, p FDR = 6.2 × 10 −5 − 4.7 × 10 −2 ). These negative interactions were not significant with shorter time spans (baseline to 2‐year follow‐up and 2‐ to 4‐year follow‐up). In conclusion, we replicated findings from cross‐sectional cohorts of the effects of FH and SLEs on lower WM integrity in youths. The study utilized Big Data longitudinal design to show that FH‐by‐SLE interaction, rather than their independent effects was responsible for developmental WM changes associated with FH of SUDs and life stressors.
- 19 October 2025
- Published by Wiley in Addiction Biology
- Vol. 30 (10) , e70089
Open AccessFamily History of Substance Use and Stressful Life Events Impact Adolescent Maturation of Cerebral White Matter
Family history (FH) of substance use disorders (SUDs) and stressful life events (SLEs) are known risk factors for SUDs in adolescents and young adults. Cross‐sectional studies suggest that FH and SLEs affect adolescent white matter (WM) development and form abnormal WM patterns. Here, we examined the effects of FH, SLEs and their interaction on WM integrity in youths in the Adolescent Cognitive Brain Development (ABCD) study at baseline and 2‐ and 4‐year follow‐ups. ABCD youths ( N = 8939, age ± SD = 9.9 ± 0.6 years, 4302 female) completed baseline diffusion tensor imaging, of which 5661 repeated the scan at 2‐year follow‐up (age ± SD = 12.0 ± 0.7 years, 2634 female) and 2177 at 4‐year follow‐up (age ± SD = 14.1 ± 0.7 years, 1007 female). FH was measured as the weighted sum of biological parents and grandparents with alcohol and/or drug problems. SLEs were measured with parental report of life events. WM integrity was measured with fractional anisotropy (FA) of 23 WM tracts. Linear mixed effect models were used to examine the effects of FH, SLEs and their interaction on FA at baseline and longitudinally, modelling family and study site as random intercepts and correcting for multiple comparisons with false discovery rate (FDR) q = 0.05. At baseline, there were no significant effects of FH, SLEs and their interaction on FA after multiple comparison correction when controlling for race, family income and parental education. From baseline to 4‐year follow‐up, FH significantly negatively interacted with newly occurred SLEs on FA in 19 out of 23 tracts, so that FA at 4‐year was lower in youths with both FH and newly occurred SLEs when controlling for baseline FA ( β interaction = −0.049 − −0.018, p FDR = 6.2 × 10 −5 − 4.7 × 10 −2 ). These negative interactions were not significant with shorter time spans (baseline to 2‐year follow‐up and 2‐ to 4‐year follow‐up). In conclusion, we replicated findings from cross‐sectional cohorts of the effects of FH and SLEs on lower WM integrity in youths. The study utilized Big Data longitudinal design to show that FH‐by‐SLE interaction, rather than their independent effects was responsible for developmental WM changes associated with FH of SUDs and life stressors.
- Open Access
- 21 July 2025
- Published by MDPI AG in Psychiatry International
- Vol. 6 (3) , 87
Dysregulated Neuroimmune and Anhedonia-like Behavioral Response Following Peripheral Immune Challenge in Mice Carrying the Val66Met Brain-Derived Neurotrophic Factor Polymorphism
Dysregulated inflammatory processes contribute to depression, and gene–environment interactions may influence an individual’s risk and resilience. Reduced brain-derived neurotrophic factor (BDNF) expression increases susceptibility for developing depressive symptoms, and the Val66Met (rs6265) single-nucleotide polymorphism (SNP) on the BDNF gene is linked to mood disorders. However, whether Val66Met confers increased vulnerability to inflammation-induced depressive tendencies is unknown. Here, we tested the hypothesis that the Val66Met SNP increases vulnerability to inflammation-induced depressive symptoms in a mouse model of lipopolysaccharide (LPS)-induced depression-like behavior. Behavior and neuroinflammation, following a 24 h LPS challenge, were measured in mice expressing the human BDNF Val66Met gene variant or Val66Val littermates (control). The Val66Met genotype did not affect the peripheral inflammatory response, acute neuroinflammation, or the acute sickness behavior response. Val66Met mice exhibited anhedonia-like behavioral responses following LPS challenge, and we found increased mRNA expression of IL-1β and TNFα in the cerebrum compared to controls. The mRNA expression of IL-1β and TNFα in the hippocampus and the nucleus accumbens of Val66Met mice was increased following LPS, and a significant genotype × LPS interaction was detected for CD68 expression in the nucleus accumbens. In summary, these data suggest that immune activation in Val66Met mice increased susceptibility to anhedonic behavior and dysregulated negative regulation of inflammation.
- 21 July 2025
- Published by MDPI AG in Psychiatry International
- Vol. 6 (3) , 87
Open AccessDysregulated Neuroimmune and Anhedonia-like Behavioral Response Following Peripheral Immune Challenge in Mice Carrying the Val66Met Brain-Derived Neurotrophic Factor Polymorphism
Dysregulated inflammatory processes contribute to depression, and gene–environment interactions may influence an individual’s risk and resilience. Reduced brain-derived neurotrophic factor (BDNF) expression increases susceptibility for developing depressive symptoms, and the Val66Met (rs6265) single-nucleotide polymorphism (SNP) on the BDNF gene is linked to mood disorders. However, whether Val66Met confers increased vulnerability to inflammation-induced depressive tendencies is unknown. Here, we tested the hypothesis that the Val66Met SNP increases vulnerability to inflammation-induced depressive symptoms in a mouse model of lipopolysaccharide (LPS)-induced depression-like behavior. Behavior and neuroinflammation, following a 24 h LPS challenge, were measured in mice expressing the human BDNF Val66Met gene variant or Val66Val littermates (control). The Val66Met genotype did not affect the peripheral inflammatory response, acute neuroinflammation, or the acute sickness behavior response. Val66Met mice exhibited anhedonia-like behavioral responses following LPS challenge, and we found increased mRNA expression of IL-1β and TNFα in the cerebrum compared to controls. The mRNA expression of IL-1β and TNFα in the hippocampus and the nucleus accumbens of Val66Met mice was increased following LPS, and a significant genotype × LPS interaction was detected for CD68 expression in the nucleus accumbens. In summary, these data suggest that immune activation in Val66Met mice increased susceptibility to anhedonic behavior and dysregulated negative regulation of inflammation.
- Open Access
- 4 July 2025
- Published by MDPI AG in Preprints.org
Dysregulated Neuroimmune and Anhedonia-like Behavioral Response Following Peripheral Immune Challenge in Mice Carrying the Val66Met Brain Derived Neurotrophic Factor Polymorphism
Dysregulated inflammatory processes contribute to depression, and gene-environment interactions may influence an individual’s risk and resilience. Reduced brain-derived neurotrophic factor (BDNF) expression increases susceptibility for developing depressive symptoms and the Val66Met (rs6265) single nucleotide polymorphism (SNP) on the BDNF gene is linked to mood disorders. However, whether Val66Met confers increased vulnerability to inflammation-induced depressive tendencies is unknown. Here, we tested the hypothesis - Val66Met SNP increases vulnerability to inflammation-induced depressive symptoms in a mouse model of lipopolysaccharide (LPS)-induced depression-like behavior. Behavior and neuroinflammation, following a 24hr LPS challenge, were measured in mice expressing human BDNF Val66Met gene variant or Val66Val littermates (control). The Val66Met genotype did not affect the peripheral inflammatory response, acute neuroinflammation, or the acute sickness behavior response. Val66Met mice exhibited anhedonia-like behavioral response following LPS challenge, and we found increased mRNA expression of IL-1β and TNFα in the cerebrum compared to controls. The mRNA expression of IL-1β and TNFα in the hippocampus and the nucleus accumbens of Val66Met mice were increased following LPS, and an interaction was detected for CD68 expression in the nucleus accumbens. In summary, these data suggest immune activation in Val66Met mice increased susceptibility to anhedonic behavior and dysregulated negative regulation of inflammation.
- 4 July 2025
- Published by MDPI AG in Preprints.org
Open AccessDysregulated Neuroimmune and Anhedonia-like Behavioral Response Following Peripheral Immune Challenge in Mice Carrying the Val66Met Brain Derived Neurotrophic Factor Polymorphism
Dysregulated inflammatory processes contribute to depression, and gene-environment interactions may influence an individual’s risk and resilience. Reduced brain-derived neurotrophic factor (BDNF) expression increases susceptibility for developing depressive symptoms and the Val66Met (rs6265) single nucleotide polymorphism (SNP) on the BDNF gene is linked to mood disorders. However, whether Val66Met confers increased vulnerability to inflammation-induced depressive tendencies is unknown. Here, we tested the hypothesis - Val66Met SNP increases vulnerability to inflammation-induced depressive symptoms in a mouse model of lipopolysaccharide (LPS)-induced depression-like behavior. Behavior and neuroinflammation, following a 24hr LPS challenge, were measured in mice expressing human BDNF Val66Met gene variant or Val66Val littermates (control). The Val66Met genotype did not affect the peripheral inflammatory response, acute neuroinflammation, or the acute sickness behavior response. Val66Met mice exhibited anhedonia-like behavioral response following LPS challenge, and we found increased mRNA expression of IL-1β and TNFα in the cerebrum compared to controls. The mRNA expression of IL-1β and TNFα in the hippocampus and the nucleus accumbens of Val66Met mice were increased following LPS, and an interaction was detected for CD68 expression in the nucleus accumbens. In summary, these data suggest immune activation in Val66Met mice increased susceptibility to anhedonic behavior and dysregulated negative regulation of inflammation.
- Open Access
- 18 November 2024
- Published by Wiley in Addiction Biology
- Vol. 29 (11) , e70000
Increased white blood cell in young adults with family histories of alcohol and other substance use disorders
Individuals with a family history of alcohol or other substance use disorders (FH+) are at increased risk for developing alcohol and other substance use disorders (AUD/SUD) compared to individuals with no such family histories (FH−). FH+ young adults have blunted stress reactivity, lower cognitive performance and altered frontal white matter microstructure compared to FH− controls. We hypothesized that family history of AUD/SUD disrupts neuroendocrine regulation of the immune system in FH+ individuals, resulting in altered blood immune cell composition, inflammation and neurocognitive alterations that, ultimately, increases risk for AUD/SUD and associated psychopathology. We examined white blood cell (WBC) parameters derived from complete blood counts in FH+ (n = 37) and FH− (n = 77) young adults without AUD/SUD to test if immune system dysregulation is present in FH+ individuals. The total WBC count, number of neutrophils and number of monocytes and associated systemic inflammatory response index (SIRI) were significantly increased in the FH+ group. Further, WBC, neutrophil, monocyte counts and SIRI values were all positively correlated with FH density (number of biological parents and grandparents with AUD/SUD). These novel data are the first to identify an association between family history of AUD/SUD and increased circulating leukocytes, which is likely indicative of immune dysregulation in FH+ young adults prior to onset of AUD/SUD. Additional studies are warranted to characterize the functional relevance of the observed immune cell composition in FH+ individuals, but the notion that inexpensive and widely available blood tests may help identify addiction risk could be transformative.
- 18 November 2024
- Published by Wiley in Addiction Biology
- Vol. 29 (11) , e70000
Open AccessIncreased white blood cell in young adults with family histories of alcohol and other substance use disorders
Individuals with a family history of alcohol or other substance use disorders (FH+) are at increased risk for developing alcohol and other substance use disorders (AUD/SUD) compared to individuals with no such family histories (FH−). FH+ young adults have blunted stress reactivity, lower cognitive performance and altered frontal white matter microstructure compared to FH− controls. We hypothesized that family history of AUD/SUD disrupts neuroendocrine regulation of the immune system in FH+ individuals, resulting in altered blood immune cell composition, inflammation and neurocognitive alterations that, ultimately, increases risk for AUD/SUD and associated psychopathology. We examined white blood cell (WBC) parameters derived from complete blood counts in FH+ (n = 37) and FH− (n = 77) young adults without AUD/SUD to test if immune system dysregulation is present in FH+ individuals. The total WBC count, number of neutrophils and number of monocytes and associated systemic inflammatory response index (SIRI) were significantly increased in the FH+ group. Further, WBC, neutrophil, monocyte counts and SIRI values were all positively correlated with FH density (number of biological parents and grandparents with AUD/SUD). These novel data are the first to identify an association between family history of AUD/SUD and increased circulating leukocytes, which is likely indicative of immune dysregulation in FH+ young adults prior to onset of AUD/SUD. Additional studies are warranted to characterize the functional relevance of the observed immune cell composition in FH+ individuals, but the notion that inexpensive and widely available blood tests may help identify addiction risk could be transformative.
- Top Cited PapersOpen Access
Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
Diseases of the central nervous system (CNS) remain a significant health, social and economic problem around the globe. The development of therapeutic strategies for CNS conditions has suffered due to a poor understanding of the underlying pathologies that manifest them. Understanding common etiological origins at the cellular and molecular level is essential to enhance the development of efficacious and targeted treatment options. Over the years, neuroinflammation has been posited as a common link between multiple neurological, neurodegenerative and neuropsychiatric disorders. Processes that precipitate neuroinflammatory conditions including genetics, infections, physical injury and psychosocial factors, like stress and trauma, closely link dysregulation in kynurenine pathway (KP) of tryptophan metabolism as a possible pathophysiological factor that ‘fuel the fire’ in CNS diseases. In this study, we aim to review emerging evidence that provide mechanistic insights between different CNS disorders, neuroinflammation and the KP. We provide a thorough overview of the different branches of the KP pertinent to CNS disease pathology that have therapeutic implications for the development of selected and efficacious treatment strategies.
Top Cited PapersOpen AccessNeuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
Diseases of the central nervous system (CNS) remain a significant health, social and economic problem around the globe. The development of therapeutic strategies for CNS conditions has suffered due to a poor understanding of the underlying pathologies that manifest them. Understanding common etiological origins at the cellular and molecular level is essential to enhance the development of efficacious and targeted treatment options. Over the years, neuroinflammation has been posited as a common link between multiple neurological, neurodegenerative and neuropsychiatric disorders. Processes that precipitate neuroinflammatory conditions including genetics, infections, physical injury and psychosocial factors, like stress and trauma, closely link dysregulation in kynurenine pathway (KP) of tryptophan metabolism as a possible pathophysiological factor that ‘fuel the fire’ in CNS diseases. In this study, we aim to review emerging evidence that provide mechanistic insights between different CNS disorders, neuroinflammation and the KP. We provide a thorough overview of the different branches of the KP pertinent to CNS disease pathology that have therapeutic implications for the development of selected and efficacious treatment strategies.